Infusion Therapy Devices Market Size (2023 - 2030)

The global infusion therapy devices market size is estimated to reach USD 11.2 billion by 2030 with a CAGR of 5.0% during the forecast period 2023 - 2030.  

Infusion therapy devices are intravenous therapy which is an effective replacement for indifferent oral medication. Infusion therapy is the most familiar pain relief treatment procedure particularly for diseases where oral medication is less effective. 

The sudden emergence of the novel coronavirus (COVID-19) has negatively affected the infusion therapy devices market. The enlargement of alternate care is set to have a negative influence and many healthcare markets are showing interest in alternate care as it relieves pain and strain in hospitals. During the pandemic period, the infusion therapy devices market and has become prominent. 

Market Drivers

The infusion therapy devices market is driven by rising chronic diseases with a huge patient population, growing demand for infusion therapy devices in-home care, and an increasingly elderly population. The increasing number of hospitals and clinics with growing demand for infusion therapies and hospitals are equipped with well-developed medical equipment and advanced technologies in the devices. 

Market Restrains

Factors like the expensive nature of the infusion therapy devices and the danger associated with infusion therapy like infiltration and hematoma limit the infusion therapy devices market growth during the forecast period. Infusion therapies are difficult to govern and the regular need of patients to visit their healthcare professionals restricting the market growth. Threats associated with drug administration and misleading device usage and unfavorable reimbursement policies obstruct the infusion therapy devices market growth.

INFUSION THERAPY DEVICES MARKET REPORT COVERAGE

To learn more about this report, download a sample copy

Segmentation Analysis

The global infusion therapy devices market has been segmented and sub-segmented according to the following categories: 

Infusion Therapy Devices Market - By Infusion Pumps

• Large Volume Infusion Therapy Devices

• Syringe Infusion Pumps

• Patient-Controlled Analgesia Infusion Therapy Devices

• Ambulatory Infusion Pumps

• Chemotherapy Infusion Pumps

• Disposable Infusion Pumps 

• Enteral Infusion Pumps

• Insulin Infusion Pumps 

• Implantable Infusion Pumps

By infusion pumps, large volume infusion therapy devices dominate the infusion market with a share of more than 35%.  The chemotherapy infusion pumps are experiencing quick growth with the highest CAGR growth rate of 8.9%

Infusion Therapy Devices Market - By Infusion Methods

• Intravenous

• Arterial

• Subcutaneous

• Epidural

Infusion Therapy Devices Market - By Infusion Type

• Continous Infusion

• Intermittent Fusion

• Infusion-on-Demand

• Total Parenteral Infusion

Infusion Therapy Devices Market - By Pump Operation Type

• Syringe Pump

• Elastomeric Pump

• Peristaltic Pump

• Multi-Channel Pump

• Smart Pump

Infusion Therapy Devices Market - By Consumables and Accessories

• I.V. Sets
• Infusion Sets
• Docking Stations
• Needleless Connectors
• Pump Reservoirs/Cartridges
• Valves and Filters
• Wireless Connectivity
• Barcode Readers
• Infusion Data Management/Analysis Software
• Others

The intravenous sets segment is witnessed to record the highest CAGR rate throughout the historical period. The needleless connectors’ infusion therapy device segment is experiencing the highest growth.

Infusion Therapy Devices Market - By Application

• Chemotherapy
• Antibiotics
• Enteral Nutrition
• Pain Management
• Parenteral Nutrition
• Hydration
• Others

By application, the chemotherapy segment dominates the infusion therapy devices market with a CAGR of 4.9% during the timeline period. The increasing cancer occurrence rate and consequent rise in demand for chemotherapy boom the infusion therapy devices market. 

Infusion Therapy Devices Market - By End-User

• Hospitals
• Clinics
• Home Healthcare

The home healthcare end-user segment is leading the infusion therapy devices market attributing to the advantages related to home infusion therapy including developed symptom management, augmented patient monitoring systems, and comfort of the patient. The swift technologies in infusion therapy technologies benefitted the substitute of receiving infusion therapy in homecare settings. 

Regional Analysis

Geographically, North America is dominating the infusion therapy devices market globally. The growth owes to rising elderly people, rising a high number of chronic disorders, and the number of diagnostic centers is surging with the increase in the patient population. Patients taking rest at home receive all types of medication and medical assistance that includes drugs and biologics. In the U.S, nearly 46.5 million surgical procedures were performed, as per the Center for Diseases Control and Prevention. People aged 65 years and above are around 49.2 million in 2016, in the U.S. as per the U.S. census bureau. 

The European infusion therapy devices market is witnessing a prominent growth rate throughout the historical period due to the increasing acquisitions among the organizations. In January 2015, in Germany, Air Liquide acquired Optical Medical Therapies for expanding business in the infusion therapy devices market. The increasing adoption of non-hospital techniques and huge elderly people who need infusion treatment regularly. The rising expenditure of healthcare, nourishing medical device sector, and growing advanced treatment opportunities boost the European infusion therapy devices market growth. 

However, Asia-Pacific is the brisk growing region with substantial growth over the period. Rising knowledge among the patients about infusion therapy devices and rising acceptance of technological advancements stimulate market growth. 

The Chinese infusion therapy devices market is predicted to grow with a CAGR of 7.3% owing to favorable healthcare reforms, and growing cancer cases among the middle-aged population and youth. China recorded 4.2 million cancer cases in 2018, as per WHO.

The Indian infusion therapy devices market is growing with a considerable CAGR rate of 9.2% during the forecast period. In India, the market growth owes to rising chronic diseases like cancer, and the Indian government is highly working for developing awareness in people about cancer by organizing some campaigns. The Indian Cancer Society has organized more than 5000 Cancer awareness programs where 635,000 patients were facilitated, since 1987. 

Latin American infusion therapy devices market is projected to register considerable growth over the timeline period. The growth owes to growing business expansion by the key players of the infusion therapy devices market. 

The Middle East & African infusion therapy states market is anticipated to have notable growth over the forthcoming years. In MEA, UAE and Saudi Arabia are the largest contributors in the infusion therapy devices market due to the augment in the healthcare industry and increasing availability of specialty care centers.

Infusion Therapy Devices Market Key Players

Hospira, Inc.(U.S.), B. Braun Melsungen AG (Germany), Caesarea Medical Electronics (Israel), Fresenius Kabi AG, Care Fusion Inc., JMSCo. Ltd., Baxter (U.S.), Terumo Corporation (Japan), Novartis, Roche Diagnostics, Kimberly-Clark Corp are some of the prominent players operating in the global infusion therapy devices market. 

Notable Happenings in the global Infusion Therapy Devices Market

• On May 10, 2022, Hospira announced its recall of EG6023of 0.5% Bupivacaine Hydrochloride Injection, USP 30mL, and lot EG8933 of 1% Lidocaine HCl Injection, USP 30mL. The product recall is due to false labeling of the part each lot as other product. 
• On April 13, 2022, the U.S FDA issued Emergency Use Authorization (EUA) for B.Braun's Perfusor Space Syringe Infusion Pump, Infusomat Space Volumetric Infusion Pumps, and Outlook ES Pump systems for use in the tracheal delivery of continuous nebulized medications into a nebulizer. It is used to treat patients of all ages suffering from the novel coronavirus (COVID-19).